Learn About Urticaria Pigmentosa

What is the definition of Urticaria Pigmentosa?

Urticaria pigmentosa is a skin disease that produces patches of darker skin and very bad itching. Hives can develop when these skin areas are rubbed.

Save information for later
Sign Up
What are the alternative names for Urticaria Pigmentosa?

Mastocytosis; Maculopapular cutaneous mastocytosis; Diffuse cutaneous mastocystosis

What are the causes of Urticaria Pigmentosa?

Urticaria pigmentosa occurs when there are too many inflammatory cells (mast cells) in the skin. Mast cells are immune system cells that help the body fight infections. Mast cells make and release histamine, which causes nearby tissues to become swollen and inflamed.

Things that can trigger histamine release and skin symptoms include:

  • Rubbing the skin
  • Infections
  • Exercise
  • Drinking hot liquids, eating spicy food
  • Temperature changes, such as heat or cold
  • Stress or anxiety
  • Medicines, such as aspirin or other NSAIDs, codeine, morphine, x-ray dye, some anesthesia medicines, and alcohol

Urticaria pigmentosa is most common in children. It can also occur in adults.

What are the symptoms of Urticaria Pigmentosa?

The main symptom is brownish patches on the skin. These patches contain cells called mastocytes. When mastocytes release the chemical histamine, the patches develop into hive-like bumps. Younger children may develop a blister that is filled with fluid if the bump is scratched.

The face may also get red quickly.

In severe cases, these symptoms may occur:

  • Diarrhea
  • Fainting (uncommon)
  • Headache
  • Wheeze
  • Rapid heartbeat
  • Abdominal pain
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Urticaria Pigmentosa?

Avoid histamine release triggers.Triggers include insect bites and stings, exposure to temperature extremes, certain medicines, and rubbing the skin lesions.

Antihistamine medicines can help relieve symptoms such as itching and flushing. Talk to your provider about which type of antihistamine to use. Corticosteroids applied on the skin and light therapy can also be used in some cases.

Your provider may prescribe other kinds of medicine to treat symptoms of severe and unusual forms of urticaria pigmentosa.

Who are the top Urticaria Pigmentosa Local Doctors?
Highly rated in

Technical University Of Munich

Munich, BY, DE 80802

Prof Brockow is in Munich, Germany. Brockow is rated as a Distinguished expert by MediFind in the treatment of Urticaria Pigmentosa. They are also highly rated in 18 other conditions, according to our data. Their top areas of expertise are Anaphylaxis, Urticaria Pigmentosa, Systemic Mastocytosis, and Hives.

Highly rated in

Odense University Hospital

Odense, DK 

Thomas Kristensen is in Odense, Denmark. Kristensen is rated as a Distinguished expert by MediFind in the treatment of Urticaria Pigmentosa. He is also highly rated in 5 other conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Urticaria Pigmentosa, Anaphylaxis, and Myeloproliferative Neoplasms.

Learn about our expert tiers
Learn more
Highly rated in

Hôpital Necker Enfants Malades

Necker Enfants Malades Hospital 
Paris, FR 

Sylvie Fraitag is in Paris, France. Fraitag is rated as a Distinguished expert by MediFind in the treatment of Urticaria Pigmentosa. She is also highly rated in 56 other conditions, according to our data. Her top areas of expertise are Infantile Myofibromatosis, Pityriasis Lichenoides, Pityriasis Lichenoides Et Varioliformis Acuta, and Pityriasis Lichenoides Chronica.

What is the outlook (prognosis) for Urticaria Pigmentosa?

Urticaria pigmentosa goes away by puberty in about one half of affected children. Symptoms usually get better in others as they grow into adulthood.

In adults, urticaria pigmentosa can lead to systemic mastocytosis. This is a serious condition that can affect bones, the brain, nerves, and the digestive system.

What are the possible complications of Urticaria Pigmentosa?

The main problems are discomfort from itching and concern about the appearance of the spots. Other problems such as diarrhea and fainting are rare.

Insect stings may also cause a bad allergic reaction in people with urticaria pigmentosa. Ask your provider if you should carry an epinephrine kit to use if you get a bee sting.

When should I contact a medical professional for Urticaria Pigmentosa?

Call your provider if you notice symptoms of urticaria pigmentosa.

Urticaria pigmentosa in the armpit
Mastocytosis - diffuse cutaneous
Urticaria pigmentosa on the chest
Urticaria pigmentosa - close-up
What are the latest Urticaria Pigmentosa Clinical Trials?
Evaluation of the Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser : Pilot Study Conducted at a Reference Centre Mastocytoses (LaserMasto)
Match to trials
Find the right clinical trials for you in under a minute
Get started
What are the Latest Advances for Urticaria Pigmentosa?
Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab.
Case Report and Review of the Literature: Bullous Skin Eruption After the Booster-Dose of Influenza Vaccine in a Pediatric Patient With Polymorphic Maculopapular Cutaneous Mastocytosis.
Tired of the same old research?
Check Latest Advances
Who are the sources who wrote this article ?

Published Date : November 04, 2020
Published By : Elika Hoss, MD, Senior Associate Consultant, Mayo Clinic, Scottsdale, AZ. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Chapman MS. Urticaria. In: Habif TP, Dinulos JGH, Chapman MS, Zug KA, eds. Skin Disease: Diagnosis and Treatment. 4th ed. Philadelphia, PA: Elsevier; 2018:chap 3.

Chen D, George TI. Mastocytosis. In: Hsi ED, ed. Hematopathology. 3rd ed. Philadelphia, PA: Elsevier; 2018:chap 20.

Wakelin SH. Dermatology. In: Feather A, Randall D, Waterhouse M, eds. Kumar and Clarke's Clinical Medicine. 10th ed. Philadelphia, PA: Elsevier Limited; 2021:chap 22.